Lucent Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
as on 06-12-2024
- Paid Up Capital ₹ 1.10 Cr
as on 06-12-2024
- Company Age 19 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 17.21 Cr
as on 06-12-2024
- Satisfied Charges ₹ 9.37 Cr
as on 06-12-2024
- Revenue 7.15%
(FY 2022)
- Profit 27.61%
(FY 2022)
- Ebitda -30.25%
(FY 2022)
- Net Worth 9.38%
(FY 2022)
- Total Assets 8.74%
(FY 2022)
About Lucent Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 1.10 Cr.
The company currently has active open charges totaling ₹17.21 Cr. The company has closed loans amounting to ₹9.37 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ragini Bansal, Anil Agrawal, Anirag Bansal, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24232UP2005PLC029816
- Company No.
029816
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
12 Apr 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Lucent Biotech Limited offer?
Lucent Biotech Limited offers a wide range of products and services, including Immunity Boosters, Vitamin C, Vitamins & Supplements, Mineral Supplements, Health Conditions, Stomach Care.
Who are the key members and board of directors at Lucent Biotech?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ragini Bansal  | Director | 16-Aug-2022 | Current |
| Anmol Bansal | Whole-Time Director | 01-Nov-2016 | Current |
| Anirag Bansal | Whole-Time Director | 15-Feb-2013 | Current |
| Anil Agrawal | Whole-Time Director | 12-Apr-2005 | Current |
| Anil Bansal | Whole-Time Director | 12-Apr-2005 | Current |
Financial Performance of Lucent Biotech.
Lucent Biotech Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 7.15% increase. The company also saw a substantial improvement in profitability, with a 27.61% increase in profit. The company's net worth moved up by a moderate rise of 9.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lucent Biotech?
In 2021, Lucent Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Mcrc Trading Private LimitedActive 25 years 6 months
Ragini Bansal and Anil Bansal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 31 Jul 2015 | ₹17.21 Cr | Open |
Sidbi Creation Date: 14 May 2020 | ₹5.00 M | Satisfied |
Bank Of Baroda Creation Date: 02 Jun 2015 | ₹0.99 M | Satisfied |
How Many Employees Work at Lucent Biotech?
Lucent Biotech has a workforce of 20 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lucent Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lucent Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
